Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 13, 2020

SELL
$6.94 - $14.42 $341,420 - $709,406
-49,196 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$6.23 - $7.98 $1.06 Million - $1.35 Million
-169,482 Reduced 77.5%
49,196 $382,000
Q3 2019

Nov 14, 2019

SELL
$5.62 - $7.86 $165,390 - $231,311
-29,429 Reduced 11.86%
218,678 $1.5 Million
Q2 2019

Aug 14, 2019

BUY
$4.53 - $7.0 $613,239 - $947,611
135,373 Added 120.08%
248,107 $1.58 Million
Q1 2019

May 15, 2019

BUY
$3.65 - $6.05 $323,682 - $536,514
88,680 Added 368.67%
112,734 $582,000
Q4 2018

Feb 14, 2019

BUY
$2.54 - $4.34 $61,097 - $104,394
24,054 New
24,054 $88,000

Others Institutions Holding ICAD

About ICAD INC


  • Ticker ICAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,333,900
  • Market Cap $73.7M
  • Description
  • iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...
More about ICAD
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.